Table 2.
The patients’ clinical information among the three groups
| CD cases(ratio) | suspected CD cases(ratio) | non-CD cases(ratio) | P | |
|---|---|---|---|---|
| Cases | 137 | 20 | 96 | |
| Sex | 0.902 | |||
| male | 102(74.50%) | 14(70.00%) | 70(72.92%) | |
| female | 35(25.50%) | 6(30.00%) | 26(27.08%) | |
| Age(y) | 15–69 | 19–59 | 14–75 | 0.020 |
| (Mean ± SD) | (33.74 ± 12.82) | (36.10 ± 11.83) | (39.08 ± 16.31) | |
| Method† | 0.020 | |||
| via mouth | 40(29.20%) | 11(55.00%) | 41(42.71%) | |
| via anus | 97(70.80%) | 9(45.00%) | 55(57.29%) | |
| Biopsy site | ||||
| ileum | 108(78.83%) | 11(55.00%) | 67(69.79%) | 0.004a |
| jejunum | 37(27.01%) | 10(50.00%) | 34(35.42%) | |
| duodenum | 0(0.00%) | 0(0.00%) | 7(7.29%) | |
| Biopsy depth | 0.186 | |||
| M ‡ | 28(20.44%) | 6(30.00%) | 32(33.33%) | |
| MM ‡ | 67(48.90%) | 10(50.00%) | 36(37.50%) | |
| SM ‡ | 42(30.66%) | 4(20.00%) | 28(29.17%) |
†:Double balloon enteroscopy examination method.
‡:M:mucosa;SM:submucosa;MM:muscularis mucosa.
aThere were no significant differences between ileum and jejunum biopsy sites